MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber’s hereditary optic neuropathy in healthy MtDNA mutations carriers
Open Access
- 9 September 2025
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 21 (5) , 1-5
Abstract
Introduction: The definition of Leber's hereditary optic neuropathy (LHON) does not take into account a preclinical phase during which the thickness of retinal nerve fiber layer (RNFL) is increased, prior to optic nerve atrophy, reducing the chances of visual recovery. Objectives: Search for a metabolomic signature characterizing this preclinical phase and identify biomarkers predicting the risk of LHON onset. Methods and results: The blood and tear metabolomic profiles of 90 asymptomatic LHON mutation carriers followed for one year will be explored as a function of RNFL thickness and compared to those of a healthy control. Conclusion: Identifying pre-clinical biomarkers would open a window for clinical trials.Keywords
Funding Information
- Université d'Angers
This publication has 20 references indexed in Scilit:
- Toxic medications in Leber's hereditary optic neuropathyMitochondrion, 2019
- Treatment strategies for Leber hereditary optic neuropathyCurrent Opinion in Neurology, 2019
- A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related DisordersInvestigative Ophthalmology & Visual Science, 2018
- International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic NeuropathyJournal of Neuro-Ophthalmology, 2017
- A neurodegenerative perspective on mitochondrial optic neuropathiesActa Neuropathologica, 2016
- Retinal Nerve Fiber Layer Thickness Variability in Leber Hereditary Optic Neuropathy CarriersEuropean Journal of Ophthalmology, 2012
- A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathyBrain, 2011
- Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategiesProgress in Retinal and Eye Research, 2011
- Genetically determined optic neuropathiesCurrent Opinion in Neurology, 2010
- Prophylaxis for Second Eye Involvement in Leber Hereditary Optic Neuropathy: An Open-Labeled, Nonrandomized Multicenter Trial of Topical Brimonidine PuriteAmerican Journal of Ophthalmology, 2005